NAPRT and central nervous system cancer: IDH1-mut glioma cells lowered NAD+ levels by silencing the NAD+ salvage enzyme nicotinic acid phosphoribosyltransferase (NAPRT) and are sensitive to the block of NAD+ biosynthesis via nicotinamide phosphoribosyltransferase (NAMPT) inhibition [28].